Operation Instant Cure: The forgotten story of COVID vaccine development
An overnight effort.
We have been told that development of mRNA COVID-19 vaccines was the result of an inspiring and herculean global effort to combat the pandemic. The carefully crafted script being repeated by powerful governments, “public health experts,” and Big Pharma outfits tells us that against all odds, the world came together to fight a powerful common enemy in this submicroscopic infectious particle known as SARS-CoV-2, and humanity prevailed. The ruling class reminds us, as often as they can, that these “scientific breakthroughs” via COVID vaccines were only possible because we pooled resources and joined hands to win this global war against the coronavirus.
While that might make for a nice Hollywood script, the true story of the COVID vaccine development process is not nearly as exciting and inspirational.
In fact, the creation and development of the two COVID mRNA vaccines that are most popular in the United States happened virtually overnight, thanks to pharmaceutical companies and their benefactors displaying oracle-like forecasting on the necessity of these projects.
Somehow, two companies that had never brought a product to market before — Boston-based Moderna and Germany’s BioNtech, both of which have received substantial funding from the Gates network — had a vaccine ready to go within days, even hours, of receiving the gene sequence from China.
And looking back on the early days of COVID Mania may leave us with more questions than answers.
On January 8 2020, the World Health Organization, in collaboration with Chinese authorities, floated the idea that dozens of pneumonia cases in the city of Wuhan may be the result of a new coronavirus. This was weeks before China went full “Wuhan Zombieland” by releasing suspicious videos of people suddenly “dropping dead” in the streets, thereby panicking the world into an endless series of lockdowns and utterly meaningless, devastating restrictions on individual liberty.
On Saturday, January 11, Chinese authorities published what they said was the genetic sequence of the novel coronavirus. Coincidentally, this event occurred on the same day that China reported the world’s first death connected to COVID-19. The first COVID-19 death outside of China (which occurred in the Philippines) would not be reported for another several weeks.
On the following Monday, just two days later, Moderna’s “infectious disease research team finalized the sequence for the SARS-CoV-2 vaccine,” according to a March press release from the company, “and Moderna mobilized toward clinical manufacture.” The first “confirmed” U.S. COVID-19 case (with shoddy, inconclusive, PCR testing) would not occur for another week.
Despite the novel virus still being a relatively unknown entity, Anthony Fauci’s NIAID displayed a seeming premonition in readying for a phase 1 study of the vaccine candidate, with development funded by the Bill Gates-funded Coalition for Epidemic Preparedness Innovations (CEPI).
Similar to Moderna, the German biotech startup BioNtech began working on their own mRNA vaccine within days of the genetic sequence being released to the world. Dubbed “Project Lightspeed,” BioNtech’s candidate (which they partnered with Pfizer on for logistics and distribution) was ready to go just days after Moderna, according to a company timeline. Just 4 months prior, The Gates Foundation made a massive pre-IPO equity investment into BioNtech.
With only one reported death worldwide, both Moderna and BioNtech — which, again, had never brought a product to market before — had the apparent foresight to invest incredible resources into COVID vaccines.
What makes this timeline even more perplexing is the fact that there was never an approved coronavirus vaccine in human history before COVID-19, yet these biotech startups with no track record of success somehow conquered those hurdles in a matter of hours and days.
Due to a variety of concerns surrounding effective deployment mechanisms and safety, a vaccine for a coronavirus was supposed to be something that would take extensive time to accomplish. Consider this fact coupled with the additional fact that pharmaceutical companies have never been able to bring an approved mRNA vaccine or therapy to market, due to similar concerns. These two facts seemed to be incredibly high hurdles to overcome. The “herculean global effort” narrative can explain this away, but now that we know about the real circumstances surrounding vaccine development, it leaves us with more questions than answers about this entire saga. “Operation Warpspeed” merely facilitated the logistics end of the COVID-19 vaccine, which was, in reality, ready to go within hours of the first death in Wuhan.